Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

2.22
Delayed Data
As of 1:21pm ET
 +0.15 / +7.25%
Today’s Change
1.90
Today|||52-Week Range
12.75
-32.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues4.0M4.4M4.2M4.0M
 
 
 
 
 
Cost of Goods Sold2.8M2.8M2.8M2.8M
 
 
 
 
 
Depreciation And Amortization330.8K356.4K340.6K300.4K
 
 
 
 
 
 
Operating ExpensesGross Income940.7K1.2M1.1M897.1K
 
 
 
 
 
General Expenses6.6M5.3M5.3M6.2M
 
 
 
 
 
Research And Development1.2M1.1M1.1M1.5M
 
 
 
 
 
Total Operating Expenses9.7M8.5M8.4M9.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.7M-4.1M-4.2M-5.3M
 
 
 
 
 
Extraordinary Credit291.0K162.0K0.00529.5K
 
 
 
 
Extraordinary Charge0.00-104.9K-497.3K0.00
 
 
 
Pre-Tax Equity Earnings-280.5K-207.0K-198.0K-342.8K
 
 
 
 
 
Interest Expense On Debt64.7K34.0K81.6K111.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-4.3M-5.0M-5.2M
 
 
 
 
 
Income Taxes-536.2K0.000.000.00
 
 
Net Income-5.2M-4.3M-5.0M-5.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.8M9.7M9.7M9.7M
 
 
 
 
 
Shares To Calculate EPS Diluted9.8M9.7M9.7M9.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.54-$0.44-$0.51-$0.56
 
 
 
 
 
EPS Diluted-$0.54-$0.44-$0.51-$0.56